Skip to content

Gyre Therapeutics, Inc. GYRE Change in Income Taxes

Change in Income Taxes at other companies

Innoviva, Inc. logo
Innoviva, Inc.INVA
$1.06M-55.5%
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
-$695K-107%
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
$37.4M+188%
Gilead Sciences logo
Gilead SciencesGILD
-$29M+94.7%

Other financials

Income statement

See full
Revenue$22.5M+2.1%
Gross profit$21.3M+0.6%
Operating income-$9.4M-512%
Net income-$8.7M-422%
EPS (diluted)-$0.10

Balance sheet

See full
Cash & equivalents$37.5M+149%
Total debt$823.0K-48.1%
Total equity$101.3M+48.7%
Total assets$162.0M+24.8%

Cash flow

See full
Operating cash flow$3.2M+2,565%
CapEx$178.0K+45.9%
Free cash flow$3.0M+1,296%

Valuation

See full
Market cap$694.58M-4.7%
Enterprise value$657.9M-8.0%
P/S5.9×-1.3×

Profitability

See full
Gross margin95.1%-1.1pp
Operating margin-0.1%-10.4pp
Net margin6.3%+3.3pp
FCF margin2.6%

Returns & leverage

See full
Return on equity8.2%+4.2pp
Debt / equity0.0×
Current ratio4.6×+1.0×

Where this comes from

Reported directly by Gyre Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable.

The official record: Gyre Therapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Gyre Therapeutics, Inc.'s change in income taxes.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Gyre Therapeutics, Inc.'s change in income taxes?
Gyre Therapeutics, Inc. (GYRE) reported change in income taxes of $144K in Q1 2026.
How has Gyre Therapeutics, Inc.'s change in income taxes changed year-over-year?
Gyre Therapeutics, Inc.'s change in income taxes increased by 106.4% year-over-year, from -$2.27M to $144K.
What does change in income taxes mean?
Change in income tax receivables and payables, reflecting timing between tax accruals and cash payments.